DK0781550T3 - Bioadhæsiv farmeceutisk sammensætning til kontrolleret frigivelse af aktive bestanddele - Google Patents
Bioadhæsiv farmeceutisk sammensætning til kontrolleret frigivelse af aktive bestanddeleInfo
- Publication number
- DK0781550T3 DK0781550T3 DK96402788T DK96402788T DK0781550T3 DK 0781550 T3 DK0781550 T3 DK 0781550T3 DK 96402788 T DK96402788 T DK 96402788T DK 96402788 T DK96402788 T DK 96402788T DK 0781550 T3 DK0781550 T3 DK 0781550T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- controlled release
- active ingredients
- bioadhesive pharmaceutical
- bioadhesive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Virology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9515701A FR2742989B1 (fr) | 1995-12-29 | 1995-12-29 | Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0781550T3 true DK0781550T3 (da) | 2002-12-09 |
Family
ID=9486116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96402788T DK0781550T3 (da) | 1995-12-29 | 1996-12-18 | Bioadhæsiv farmeceutisk sammensætning til kontrolleret frigivelse af aktive bestanddele |
Country Status (15)
Country | Link |
---|---|
US (1) | US5900247A (zh) |
EP (1) | EP0781550B1 (zh) |
JP (1) | JPH09194395A (zh) |
CN (1) | CN1159950A (zh) |
AT (1) | ATE222098T1 (zh) |
AU (1) | AU725283B2 (zh) |
CA (1) | CA2193454C (zh) |
DE (1) | DE69622980T2 (zh) |
DK (1) | DK0781550T3 (zh) |
ES (1) | ES2180722T3 (zh) |
FR (1) | FR2742989B1 (zh) |
NO (1) | NO965475L (zh) |
NZ (1) | NZ314009A (zh) |
PT (1) | PT781550E (zh) |
ZA (1) | ZA9610864B (zh) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
US20050048102A1 (en) * | 1997-10-16 | 2005-03-03 | Virotex Corporation | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
US6548490B1 (en) | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
IL126447A (en) * | 1998-10-04 | 2004-09-27 | Vascular Biogenics Ltd | An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis |
US20050197283A1 (en) * | 1998-10-04 | 2005-09-08 | Vascular Biogenics Ltd. | Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease |
US6231957B1 (en) | 1999-05-06 | 2001-05-15 | Horst G. Zerbe | Rapidly disintegrating flavor wafer for flavor enrichment |
WO2001080830A2 (en) * | 2000-04-21 | 2001-11-01 | Advanced Research And Technology Institute, Inc. | Pharmacotherapeutic process and composition for central nervous system disorders |
EP1284137B1 (en) * | 2000-05-26 | 2010-12-01 | TAKADA, Kanji | Nonoral preparation having three-layer structure |
US20020013331A1 (en) * | 2000-06-26 | 2002-01-31 | Williams Robert O. | Methods and compositions for treating pain of the mucous membrane |
US6756051B1 (en) | 2000-11-15 | 2004-06-29 | Li-Lan H. Chen | Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same |
US7803392B2 (en) * | 2000-12-27 | 2010-09-28 | University Of Kentucky Research Foundation | pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules |
US6660292B2 (en) | 2001-06-19 | 2003-12-09 | Hf Flavoring Technology Llp | Rapidly disintegrating flavored film for precooked foods |
US20040241240A1 (en) * | 2001-08-10 | 2004-12-02 | Takaaki Terahara | Percutaneous absorption preparations |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US7425292B2 (en) * | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
US20030194420A1 (en) * | 2002-04-11 | 2003-10-16 | Richard Holl | Process for loading a drug delivery device |
WO2004014448A1 (en) * | 2002-08-13 | 2004-02-19 | Medtronic, Inc. | Active agent delivery system including a hydrophilic polymer, medical device, and method |
WO2004019901A2 (en) * | 2002-08-30 | 2004-03-11 | Orchid Chemicals & Pharmaceuticals Ltd. | Sustained release pharmaceutical composition |
ES2209649B1 (es) * | 2002-12-09 | 2005-03-16 | Carlos Arana Molina (Titular Al 25%) | Utilizacion de la melatonina para la higiene bucodental para uso humano y veterinario como producto activo. |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9498454B2 (en) | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7306812B2 (en) | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
DE10328942A1 (de) * | 2003-06-27 | 2005-01-27 | Lts Lohmann Therapie-Systeme Ag | Transmukosale Darreichungsformen mit verminderter Schleimhautirritation |
FR2857594B1 (fr) * | 2003-07-17 | 2005-09-16 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale de piribedil |
DE10358749A1 (de) * | 2003-12-12 | 2005-07-14 | Lts Lohmann Therapie-Systeme Ag | Darreichungsform zur Bekämpfung von primären Kopfschmerzen |
US20050281757A1 (en) * | 2004-06-17 | 2005-12-22 | Sayed Ibrahim | Oral care film |
EP1793799B1 (en) * | 2004-08-02 | 2010-05-05 | Glaxo Group Limited | Novel composition for treating xerostomia |
EP1877446A1 (en) * | 2005-03-02 | 2008-01-16 | Polyrizon Ltd. | Method for removal of toxins from mucosal membranes |
FR2901701B1 (fr) * | 2006-05-31 | 2010-10-29 | Galderma Res & Dev | Compostions comprenant au moins un derive de l'acide naphtoique et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations |
JP2009541345A (ja) | 2006-06-20 | 2009-11-26 | イズン ファーマシューティカルズ コーポレイション | 抗炎症可溶フィルム |
WO2008011556A2 (en) * | 2006-07-20 | 2008-01-24 | Izun Pharmaceuticals Corporation | Film-delivering rinse |
CN103550136B (zh) | 2006-07-21 | 2016-04-13 | 生物递送科学国际公司 | 吸收增强的经粘膜递送装置 |
EP2094080B1 (de) | 2006-11-13 | 2017-06-07 | Basf Se | Verwendung von blockcopolymeren auf basis von vinyllactamen und vinylacetat als solubilisatoren |
CN101636480B (zh) | 2007-01-11 | 2014-04-09 | 诺维信公司 | 包含活性化合物的颗粒 |
EP3056220A1 (en) * | 2007-04-11 | 2016-08-17 | John A. Mccarty | Hormone tablet and metods of preparation |
US20120027855A1 (en) | 2007-07-06 | 2012-02-02 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
EP3620153A1 (en) | 2007-07-06 | 2020-03-11 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
WO2009008006A2 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
US20110136815A1 (en) | 2009-12-08 | 2011-06-09 | Horst Zerbe | Solid oral film dosage forms and methods for making same |
US10610528B2 (en) | 2009-12-08 | 2020-04-07 | Intelgenx Corp. | Solid oral film dosage forms and methods for making same |
JP5819949B2 (ja) | 2010-06-10 | 2015-11-24 | ミダテック リミテッド | ナノ粒子フィルム送達システム |
EP2397125A1 (en) | 2010-06-15 | 2011-12-21 | Histocell, S.L. | Antioxidant composition |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
ES2660116T3 (es) | 2011-08-18 | 2018-03-20 | Biodelivery Sciences International, Inc. | Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina |
JP2013095687A (ja) * | 2011-10-31 | 2013-05-20 | Tsukioka Film Pharma Co Ltd | 口腔内貼付薬 |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
WO2015120471A1 (en) * | 2014-02-10 | 2015-08-13 | The Johns Hopkins University | Devices for and methods of treatment of metabolic syndromes |
EP3331499A4 (en) | 2015-08-06 | 2019-04-10 | The Johns Hopkins University | COMPOSITION AND METHOD OF TREATING METABOLIC DISORDERS |
JP2019519487A (ja) | 2016-05-05 | 2019-07-11 | アクエスティブ セラピューティクス インコーポレイテッド | 送達増強エピネフリン組成物 |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045914A1 (de) * | 1980-12-05 | 1982-07-22 | Bayer Ag, 5090 Leverkusen | Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern |
IL61721A (en) * | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
JPH0729915B2 (ja) * | 1986-02-01 | 1995-04-05 | 帝國製薬株式会社 | シ−ト状口腔内貼付剤 |
JPH0794384B2 (ja) * | 1986-09-01 | 1995-10-11 | 帝国製薬株式会社 | 徐放性口腔内用製剤 |
JPS63171564A (ja) * | 1987-01-07 | 1988-07-15 | 積水化学工業株式会社 | 口腔粘膜貼付用構成体およびその製造方法 |
JPS63265983A (ja) * | 1987-04-23 | 1988-11-02 | Sekisui Chem Co Ltd | 親水性粘着剤組成物 |
JPH01268630A (ja) * | 1988-04-19 | 1989-10-26 | Nitto Denko Corp | 徐放性製剤 |
PH26730A (en) * | 1988-12-30 | 1992-09-28 | Ciba Geigy Ag | Coated adhesive tablets |
US5527545A (en) * | 1989-09-18 | 1996-06-18 | Recordati S.A. Chemical And Pharmaceutical Company | Liquid-suspension controlled-release pharmaceutical composition |
FR2710265B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
-
1995
- 1995-12-29 FR FR9515701A patent/FR2742989B1/fr not_active Expired - Fee Related
-
1996
- 1996-12-18 DK DK96402788T patent/DK0781550T3/da active
- 1996-12-18 DE DE69622980T patent/DE69622980T2/de not_active Expired - Fee Related
- 1996-12-18 ES ES96402788T patent/ES2180722T3/es not_active Expired - Lifetime
- 1996-12-18 AT AT96402788T patent/ATE222098T1/de not_active IP Right Cessation
- 1996-12-18 PT PT96402788T patent/PT781550E/pt unknown
- 1996-12-18 EP EP96402788A patent/EP0781550B1/fr not_active Expired - Lifetime
- 1996-12-19 NO NO965475A patent/NO965475L/no not_active Application Discontinuation
- 1996-12-19 CA CA002193454A patent/CA2193454C/fr not_active Expired - Fee Related
- 1996-12-23 NZ NZ314009A patent/NZ314009A/en unknown
- 1996-12-23 ZA ZA9610864A patent/ZA9610864B/xx unknown
- 1996-12-23 AU AU75496/96A patent/AU725283B2/en not_active Ceased
- 1996-12-24 JP JP8343671A patent/JPH09194395A/ja active Pending
- 1996-12-27 US US08/777,306 patent/US5900247A/en not_active Expired - Fee Related
- 1996-12-27 CN CN96123198A patent/CN1159950A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2193454A1 (fr) | 1997-06-30 |
AU725283B2 (en) | 2000-10-12 |
EP0781550A1 (fr) | 1997-07-02 |
AU7549696A (en) | 1997-07-03 |
NO965475D0 (no) | 1996-12-19 |
US5900247A (en) | 1999-05-04 |
EP0781550B1 (fr) | 2002-08-14 |
FR2742989B1 (fr) | 1998-01-23 |
CN1159950A (zh) | 1997-09-24 |
ZA9610864B (en) | 1997-06-27 |
ATE222098T1 (de) | 2002-08-15 |
FR2742989A1 (fr) | 1997-07-04 |
DE69622980D1 (de) | 2002-09-19 |
ES2180722T3 (es) | 2003-02-16 |
DE69622980T2 (de) | 2003-04-10 |
NO965475L (no) | 1997-06-30 |
CA2193454C (fr) | 2001-07-24 |
NZ314009A (en) | 1998-02-26 |
JPH09194395A (ja) | 1997-07-29 |
PT781550E (pt) | 2002-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0781550T3 (da) | Bioadhæsiv farmeceutisk sammensætning til kontrolleret frigivelse af aktive bestanddele | |
ATE197899T1 (de) | Bioadhesive pharmazeutische zusammensetzung zur kontrollierten freigabe von wirkstoffen | |
AU6517496A (en) | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole | |
DE69533492D1 (de) | Orale Metoprolol-Dosisform des Typs "einmal täglich" | |
AU5274093A (en) | Tablet for administering pharmaceutical compositions | |
CA2274485A1 (en) | Medicinal composition | |
AU651894B2 (en) | Matrix tablet permitting the sustained release of indapamide after oral administration | |
IS4553A (is) | Lyfjablöndur sem innihalda mónóamín oxídasa B blokkara | |
FI951357A (fi) | Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen | |
TW374729B (en) | 4-biphenylylacetate-containing medicated plaster | |
DK404486D0 (da) | Medikament-polymergrundmasse-praeparat og fremgangsmaade til dets fremstilling | |
AU3756797A (en) | Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance | |
FI963394A (fi) | Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia | |
ATE20311T1 (de) | Polymerische diffusionsmatritze propranolol enthaltend. | |
ATE244559T1 (de) | Verwendung von n-vinylpyrrolidon-und vinylacetat- haltigen copolymeren als matrix zur herstellung von festen, oralen, pharmazeutischen und kosmetischen zubereitungen | |
IT1317871B1 (it) | Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche. |